Setti E L, Micetich R G
Medicinal Chemistry Division, SynPhar Laboratories Inc., #2 4290-91 St., Edmonton, Alta. T6E 5V2, Canada.
Curr Med Chem. 1998 Apr;5(2):101-13.
The continual evolution of microbial resistance to the available classes of antibiotics poses a serious threat to the efficacy of traditional antibacterial therapy. Today, there are two main approaches that are being applied to discover better and more effective anti-infective agents against common as well as resistant pathogens: (a) the improvement of the "classical" antimicrobial agents by targeting the so called "resistance factors", and (b) the search of new anti-infective agents with novel modes of actions. This review will highlight the most relevant aspects of both of these approaches and some of the latest findings in the field of antimicrobial discovery.
微生物对现有各类抗生素的耐药性不断演变,对传统抗菌治疗的疗效构成了严重威胁。如今,有两种主要方法被用于发现针对常见病原体以及耐药病原体的更好、更有效的抗感染药物:(a)通过靶向所谓的“耐药因子”来改进“经典”抗菌药物;(b)寻找具有新型作用模式的新型抗感染药物。本综述将重点介绍这两种方法的最相关方面以及抗菌药物发现领域的一些最新研究成果。